Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing by Bhattacharjee, Rakesh et al.
RESEARCH ARTICLE Open Access
Endothelial dysfunction in obese
non-hypertensive children without evidence of
sleep disordered breathing
Rakesh Bhattacharjee
1, Wadha H Alotaibi
1, Leila Kheirandish-Gozal
1, Oscar Sans Capdevila
1, David Gozal
1,2*
Abstract
Background: Endothelial dysfunction is a complication of both obesity and obstructive sleep apnea syndrome
(OSAS), the latter being highly prevalent among obese children. It is unknown whether obesity causes endothelial
dysfunction in children in the absence of OSAS. This study examines endothelial function in obese and non-obese
children without OSAS.
Methods: Pre-pubertal non-hypertensive children were recruited. Endothelial function was assessed in a morning
fasted state, using a modified hyperemic test involving cuff-induced occlusion of the radial and ulnar arteries. The
absence of OSAS was confirmed by overnight polysomnography. Anthropometry was also performed.
Results: 55 obese children (mean age 8.6 ± 1.4 years, mean BMI z-score: 2.3 ± 0.3) were compared to 50 non-
obese children (mean age 8.0 ± 1.6 years, mean BMI z-score 0.3 ± 0.9). Significant delays to peak capillary
reperfusion after occlusion release occurred in obese compared to non-obese children (45.3 ± 21.9 sec vs. 31.5 ±
14.1 sec, p < 0.01), but no differences in the magnitude of hyperemia emerged. Time to peak reperfusion and
percentage of body fat were positively correlated (r = 0.365, p < 0.01).
Conclusions: Our findings confirm that endothelial dysfunction occurs early in life in obese children, even in the
absence of OSAS. Thus, mechanisms underlying endothelial dysfunction in pediatric obesity are operational in the
absence of sleep-disordered breathing.
Background
The obesity epidemic has raised awareness to the poten-
tial and far-reaching adverse consequences associated
with being overweight. Indeed, obesity has been asso-
ciated with an increase in the prevalence of diabetes
mellitus, dyslipidemia, hypertension, and potentially
leads to the development of the metabolic syndrome
and cardiovascular disease [1,2]. In addition, obesity
markedly increases the risk for obstructive sleep apnea
syndrome (OSAS) [3-6].
Obesity in children has nearly doubled over the past 2
decades in the United States, with approximately 15% of
all children fulfilling obesity criteria, i.e., a body mass
index (BMI) over the 95
th percentile on standard growth
curves assembled by the Centers for Disease and
Control (CDC) [7]. As a consequence of the increasing
rates of childhood obesity, and the above-listed obesity-
associated co-morbidities, the global life expectancy in
the United States is expected to decline, [8-10] and has
led to the American Heart Association as well as the
American Diabetes Associations both to re-classify obe-
sity as a ‘major, modifiable risk factor’ for cardiovascular
disease [11].
There is ample evidence suggesting that the complica-
tions of obesity in adults begin in early childhood.
Hypercholesterolemia, dyslipidemia, [9,12,13] insulin
resistance, and type 2 diabetes mellitus [14-16] have
been all described as significant co-morbidities asso-
ciated with pediatric obesity. Likely, the constellation of
these metabolic derangements accrues a significant risk
for the development of cardiovascular disease during
childhood. Furthermore, although systemic hypertension
in children is rare with an estimated prevalence at 2-5%, * Correspondence: dgozal@peds.bsd.uchicago.edu
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hypertension in children [18,19].
In addition to cardiovascular morbidity, obesity has
been linked to the development of OSAS in children, a
condition in which intermittent occlusion of the upper
airway during sleep leads to recurrent oxyhemoglobin
desaturations, elevated carbon dioxide levels, sleep frag-
mentation, and reduced sleep efficiency [4-6,20]. Among
other morbidities, OSAS independently elevates the risk
for systemic hypertension and cardiovascular disease
[21]. Recent work from our laboratory has shown that
endothelial dysfunction, an early marker of cardiovascu-
lar disease, which was assessed by a modified hyperemic
test after cuff-induced occlusion of the brachial artery,
was also present among non-obese 6-9-year-old children
who were polysomnographically diagnosed with OSAS,
and that the abnormal post-occlusive reperfusion
responses were reversed in most children by adequate
and effective treatment of their underlying OSAS [22].
Obesity in children has also been shown to induce
endothelial dysfunction [23,24]. However, although the
latter studies showed significant associations between
body fat and dyslipidemia, insulin resistance, and inflam-
mation, all of which could contribute to endothelial dys-
function, none of these studies determined whether
OSAS was concomitantly present. Thus, there is no cer-
tainty as to whether the abnormalities in endothelial
function described in obese children were specifically
linked to the obese state or to the concurrent yet
unknown presence of OSAS.
T h ep u r p o s eo ft h ec u r r e n ts t u d yw a st oi n v e s t i g a t e
the impact of obesity on endothelial dysfunction in chil-
dren by careful exclusion of children with OSAS.
Methods
The study was approved by the University of Louisville
and Kosair Children’s Hospital institutional review
boards. Informed consent from the parent or legal cus-
todian was obtained, and minor assent (for children
ages 7 and older) was administered and obtained as
well. Consecutive healthy pre-pubertal children (ages 4-
12 years) participating in a sleep and neurocognitive
research study at the University of Louisville Pediatric
Sleep Medicine Center were recruited to investigate
endothelial function. Subjects were recruited from
November 2007 until September 2008. All participants
underwent baseline overnight polysomnography and a
fasting blood draw in the morning.
Anthropometry
Children were weighed using the InBody 320 scale (Bio-
space, CA), which employs the Direct Segmental Multi-
frequency Bioelectrical Impedance Analysis method, and
therefore enables assessment of percent body fat and
determination of individual impedance indices for all
limbs. This feature allows for computation of an esti-
mate of visceral fat. Height (to 0.1 cm) was measured
with a stadiometer (Holtain, Crymych, UK). BMI was
calculated and BMI z-score was computed using CDC
2000 growth standards http://www.cdc.gov/growthcharts
and online software http://www.cdc.gov/epiinfo. A BMI
z-score >1.65 (>95
th percentile) was considered as fulfill-
ing obese criteria.
Sphygmomanometry
All children had arterial blood pressure measured non-
invasively using an automated mercury sphygmoman-
ometer (Welch Allyn, NY) at the brachial artery using a
guidelines-defined appropriate cuff size on the non-
dominant arm [25]. Two consecutive blood pressure
measurements were made while children lay supine with
the head of the bed elevated to 45°. A non-standard pos-
ture of blood pressure measurements was chosen in
order to mimic the posture utilized during endothelial
function testing, which was both comfortable for chil-
dren and best minimized arm motion artifact during
measurement. Blood pressure measurements were made
in the evening prior to commencement of nocturnal
polysomnography. Systolic and diastolic blood pressure
indices were calculated by dividing the average systolic
and diastolic pressure by the respective 95
th percentile
for blood pressure http://www.nhlbi.nih.gov/guidelines/
hypertension/child_tbl.htm computed for age, gender
a n dh e i g h t .H y p e r t e n s i o nw a sd e f i n e db yas y s t o l i co r
diastolic blood pressure index exceeding 1.
Overnight Polysomnography (PSG)
PSG was conducted and scored as previously reported
[26].
Endothelial Function
Endothelial function was assessed using a modified
hyperemic test after cuff-induced occlusion of the radial
and ulnar arteries by placing the cuff over the wrist. All
testing was performed at awakening to ensure that chil-
dren were in a fasted state. A laser Doppler sensor (Peri-
flux 5000 System integrated with the PF 5050 Pressure
Unit, Perimed, Järfälla, Sweden) was applied over the volar
aspect of the hand at the 1
st finger distal metacarpal sur-
face and the hand was gently immobilized. This site was
chosen as an area in order to minimize the effects of
motion artifact and was also found to have a density of
skin capillary blood flow that was of appropriate magni-
tude for detection. Again, children lay supine with the
head of the bed elevated 45°. Once cutaneous blood flow
over the area became stable, the pressure within an inflata-
ble cuff placed at the forearm and connected to a compu-
ter-controlled manometer was raised to 200 mmHg for 60
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levels. An occlusion time of 60 seconds was chosen in
order to minimize discomfort for the child. Using a com-
puter controlled pressure release to allow for consistent
deflation times, the cuff was rapidly deflated and the laser
Doppler measured hyperemic responses. The maneuver
was repeated twice within 10 min with at least 2 minutes
separating both trials to ensure a return to baseline perfu-
sion. The average of both maneuvers was then computed
for subsequent analyses. Laser Doppler determines the
magnitude of perfusion at rest, at occlusion and post
occlusion. While detection of microvascular perfusion var-
ies by child according to density of capillary blood vessels,
thickness of skin, etc., all measurements are extrapolated
to baseline perfusion before cuff occlusion, and analysis of
reperfusion kinetics is based on time measurements. Com-
mercially available software (Perimed, Järfälla, Sweden)
allowed for unbiased estimates of the time to peak regional
blood flow response post occlusion release, which is con-
sidered representative of the post-occlusion hyperemic
response, an index of endothelial function [27]. The mean
intra-individual coefficient of variability of the time to
peak flow was 12.8% for all trials. When the time to peak
flow in any of the subjects, in the 2 trials differed by >25%,
the test was repeated a 3
rd time, and the 2 fastest times to
peak reperfusion were retained and averaged. Only 4 of
the subjects in the current study required a 3
rd trial
Blood Tests
Fasting blood samples were drawn by venipuncture in
the morning immediately after endothelial function test-
ing and nocturnal polysomnography. Blood was sent for
routine laboratory testing including high sensitivity C-
reactive protein, glucose, insulin, and serum lipid con-
centrations, using standard laboratory techniques.
Exclusion Criteria
All hypertensive children (with either a systolic or dia-
stolic blood pressure index > 1) or using anti-hyperten-
sive therapies were excluded. Furthermore, children
with diabetes (fasting serum glucose ≥ 120 mg/dL), with
a craniofacial, neuromuscular or defined genetic syn-
drome, and children on chronic anti-inflammatory ther-
apy, or with any known acute or chronic illness were
excluded. Children using sympathomometic agents such
as psychostimulants were excluded. Finally, patients
found to snore or have OSAS during the PSG, i.e,
obstructive apnea hypopnea index (OAHI) ≥ 1.5 events/
hour TST, were excluded from the analysis.
Data Analysis
Results are presented as means ± SD, unless stated
otherwise. All numerical data were subjected to statisti-
cal analysis using independent Student t tests or analysis
of variance followed by post-hoc tests as appropriate.
No variance stabilizing transformations were underta-
ken. A 2-tailed p < 0.05 was considered to define statis-
tical significance. Chi square analysis was performed on
categorical data concerning demographic characteristics
of obese and non-obese groups.
All methods outlined in this study were approved by
the University of Louisville Human Research
Committee.
Results
In total, 161 children fitting initial inclusion criteria
were recruited. Of these, 49 children were found to have
OSAS with OAHI > 1.5/hrTST and were therefore
excluded. Six additional children were found to be
mildly hypertensive (systolic blood pressure index > 1),
and were also excluded from the study. Of the remain-
ing 105 eligible children, 55 children were obese and the
remaining 50 were designated into the non-obese group.
The mean age of non-obese and obese groups was simi-
lar (8.0 ± 1.6 years compared to 8.6 ± 1.4 years, respec-
tively; p - not significant). Gender and ethnic
distribution were also similar across both groups (Table
1). Seven children in the obese group and 7 children in
non-obese group had parents with systemic essential
hypertension or with early onset cardiovascular disease
(before age 50).
Anthropometric assessments revealed significant dif-
ferences in lean body mass, body fat mass, dry lean
mass and percent body fat across the 2 groups (Table
1). Percent body fat was 39.2% in obese children com-
pared to 16.2% in non-obese children (p < 0.01; Table
1). Obese children also exhibited significantly higher
impedances in all limbs and in the trunk, indicative of
increased visceral fat (p < 0.01; data not shown).
Overnight polysomnographic findings were similar
between both groups and within the normal values pre-
viously reported for a healthy pediatric population
(OAHI (events/hr): 0.8 ± 0.5 in the nonobese group vs.
0.9 ± 0.5, in the obese group) [28]. Apart from a signifi-
cant, albeit minor increase in the percentage of wake
time after sleep onset in the obese group, all polysom-
nographic variables were not significantly different
between the obese and non-obese cohorts (Additional
file 1, Table S4).
Blood pressure measurements, while not fulfilling any
o ft h ec r i t e r i af o rh y p e r t e n s i o ni nt h e1 0 5c h i l d r e n
included in the present study, revealed that obese chil-
dren had significantly higher mean systolic blood pres-
sures (111.6 ± 8.4 vs. 97.7 ± 7.5 mmHg, p < 0.01) and
systolic blood pressure indices (0.94 ± 0.06 vs. 0.85 ±
0.06, p < 0.01) compared to non-obese children. There
were no differences in either diastolic blood pressure or
diastolic blood pressure indices between both groups.
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in either fasting serum cholesterol, apolipoprotein B, or
triglyceride levels (Table 2), although triglyceride levels
trended towards higher levels in obese children com-
pared to non-obese children (p = 0.1) Fasting glucose or
insulin levels were similar in the 2 groups. While serum
levels of high sensitivity C-reactive protein (CRP) were
not significantly different, there appeared to be a slight
elevation in CRP in the obese group.
Endothelial Function Testing
Laser-Doppler analysis of cutaneous blood flow did not
reveal any significant differences in resting blood flow
between both groups. Release of occlusion did not
reveal any significant differences in the magnitude of
peak flow after release of occlusion. However, the time
t oa t t a i np e a kr e p e r f u s i o nf l o wi no b e s ec h i l d r e nw a s
significantly delayed in comparison to non-obese chil-
dren (45.3 ± 21.9 vs. 31.5 ± 14.1 s, p < 0.01; Table 3,
Figure 1).
The potential impact of obesity on endothelial func-
tion is further illustrated in Figure 2. Significant positive
associations emerged between BMI z-score (r = 0.31, p
< 0.01), and between percent body fat (r = 0.37, p <
0.01) and time to peak flow, suggesting that increasing
severity of obesity in children leads to increased delays
in reperfusion responses. Similarly, a positive correlation
between serum triglyceride levels and time to peak flow
was found (figure 2), thereby linking hyperlipidemia to
endothelial dysfunction (r = 0.35, p < 0.01). Using
Table 1 Demographic Characteristics of Non-Obese and Obese Cohort of Pre-Pubertal Children
Non-Obese (BMI z < 1.65) Obese (BMI z > 1.65) p value
Number of Subjects 50 55
Age years 8.0 ± 1.6 8.6 ± 1.4 NS
Gender Males 30 27 NS
Females 20 28 NS
Race White Non Hispanic 33 30 NS
African American 12 22 NS
Hispanic 10 N S
Biracial 23 N S
Other 20 N S
Family History of Cardiovascular Disease 77 N S
BMI (kg/m2) 16.8 ± 1.9 26.7 ± 4.7 p < 0.01
BMI z score 0.3 ± 0.9 2.3 ± 0.3 p < 0.01
Lean Body Mass (kg) 22.8 ± 4.0 31.2 ± 5.9 p < 0.01
Body Fat Mass (kg) 4.8 ± 2.9 21.5 ± 8.1 p < 0.01
Dry Lean Mass (kg) 6.4 ± 1.1 8.7 ± 1.6 p < 0.01
Percent Body Fat (%) 16.2 ± 7.0 39.2 ± 4.5 p < 0.01
Mean Systolic Blood Pressure (mmHg) 97.7 ± 7.5 111.6 ± 8.4 p < 0.01
Systolic Blood Pressure Index 0.85 ± 0.06 0.94 ± 0.07 p < 0.01
Mean Diastolic Blood Pressure (mmHg) 59.7 ± 6.4 62.3 ± 7.8 NS
Diastolic Blood Pressure Index 0.78 ± 0.08 0.80 ± 0.10 NS
Table 2 Blood Metabolic Profiles of Non-Obese and Obese Cohort of Pre-Pubertal Children
Non-Obese (BMI z < 1.65) Obese (BMI z > 1.65) p value
Triglycerides (mg/dL) 73.2 ± 44.5 87.0 ± 33.4 NS
Cholesterol (mg/dL) 163.5 ± 24.9 164.0 ± 28.9 NS
HDL (mg/dL) 53.8 ± 11.4 50.0 ± 10.0 NS
LDL (mg/dL) 95.1 ± 21.2 96.6 ± 24.1 NS
Glucose (mg/dL) 73.5 ± 22.8 79.0 ± 11.4 NS
Insulin (mIU/mL) 7.9 ± 11.6 11.0 ± 6.2 NS
CRP (mg/L) 1.1 ± 1.7 2.8 ± 5.1 NS
Apo-B (mg/L) 74.2 ± 16.5 77.2 ± 18.9 NS
Legend – HDL – high density lipoprotein, LDL – low density lipoportein, CRP – C-reactive protein, Apo-B – apolipoprotein B
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w h e r e b yB M Iz - s c o r ea c c o u n t e df o r2 4 . 7 %o ft h ev a r -
iance in time to peak flow, with additional significant,
albeit minor contributions by visceral fat (5.2%), but not
by lipid serum concentrations.
Discussion
T ot h eb e s to fo u rk n o w l e d g e ,t h ep r e s e n ts t u d yi st h e
first to demonstrate the presence of endothelial dysfunc-
tion in obese, non-hypertensive pre-pubertal children in
the absence of concomitant obstructive sleep apnea syn-
drome. Delays in vascular reperfusion kinetics suggest
that the integrity of the vasculature that is critical for
adequate responses to vasodilatory stimuli, such as
those operating in post-ischemic recovery responses, is
significantly compromised in obese children, and that
such impairments are correlated to the degree of dyslipi-
demia and percent body fat.
Before discussing the potential implications of our
findings, several methodological issues deserve com-
ment. First, by using a rather holistic diagnostic
approach, this study successfully recruited a large cohort
o fo b e s ec h i l d r e nw i t hn oe v i d e n c eo fO S A So ra n y
other form of sleep disordered breathing. Hence, one
can then more confidently ascribe the aberrations in
vascular function identified in these obese children to
obesity itself, and clearly rule out that these abnormal-
ities may have been imposed by some of the systemic
metabolic and oxidative stress alterations associated
w i t hO S A S .F u r t h e r ,7c h i l d r e ni ne a c ho ft h e2g r o u p s
had a significant family history of early onset hyperten-
sion or premature cardiovascular disease, and therefore,
any confounding effects of any known familial factors
contributing to early onset cardiovascular disease in the
obese group are unlikely to have played a role in the dif-
ferences in reperfusion kinetics between obese and non-
Table 3 Perfusion Kinetic Measures of Endothelial Function in Non-Obese and Obese Cohort of Pre-Pubertal Children
Non-Obese (BMI z < 1.65) Obese (BMI z > 1.65) p value
Rest Flow (PU) 21.2 ± 11.9 22.5 ± 12.6 NS
Biological Zero (BZ) (PU) 3.8 ± 2.1 3.4 ± 1.7 NS
Peak Flow (PF) (PU) 43.7 ± 25.1 44.2 ± 20.3 NS
Time to Peak Flow (s) 31.5 ± 14.1 45.3 ± 21.9 p < 0.01
Legend – PU – perfusion units
Figure 1 Cuff Occlusion Testing in a Non-obese (A) and an Obese (B) child.P U– perfusion units, PF – peak flow, RF – rest flow, BZ –
biological zero, AO – area of occlusion, AH – area of hyperemia, TM – time to peak flow following occlusion.
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were included in the study, further restricting the poten-
tial confounder effects of hypertension on the impact of
obesity on vascular function.
As previously shown by other studies, albeit without
ascertaining on the concurrent presence of OSAS,
[23,24,29,30] and now further confirmed by the current
study, the presence of endothelial dysfunction in obese
children implies that early changes leading to athero-
sclerosis may be already actively operational. The
endothelial surface of the vascular wall is the frontline
of vascular functional integrity, and is also instrumental
in the early formation of the atherogenic plaques [31].
While paracrine functioning of healthy vascular
endothelium contributes to protection against such pla-
que formation, our identification of abnormal endothe-
lial function would suggest that these homeostatic
processes are impaired, thereby posing the risk of early
onset atherosclerosis in pre-pubertal children. However,
we should point out that delineation of endothelial dys-
function by the current cutaneous vascular reperfusion
test used herein differs from flow mediated reperfusion
tests using Doppler technology assessment of a muscu-
lar artery (e.g., brachial artery), and that therefore our
current findings can not be extrapolated to other mea-
surement techniques. Further, the decision to minimize
the duration of the occlusion such as to prevent discom-
fort and motion in very young children may limit gener-
alizability of the technique.
We have previously shown that OSAS is associated with
reversible injury to the vascular endothelium in non-obese
children and that these pathological processes were rever-
sible in the vast majority of children upon effective treat-
ment of OSAS [22]. Furthermore, the presence of a strong
family history of early cardiovascular disease in a subset of
~20% of these children was associated with lack of reversi-
bility of endothelial hyperemic delays at 6 months after
treatment. In the present study, we excluded any child
with altered sleep-associated breathing abnormalities pat-
terns, and, thus, our current findings more definitively
confirm that endothelial dysfunction associated with obe-
sity occurs independently of OSAS. Nevertheless, it is
likely that both obesity- and OSAS-associated mechanisms
of vascular dysfunction overlap, and may in fact synergisti-
cally interact and converge; such as to induce amplified
injury to the vascular endothelium through possible shared
inflammatory, vasoconstrictor and pro-atherothrombotic
pathways [32].
While obese children studied herein were not hyper-
tensive, and yet, obesity was associated with increases in
systolic blood pressure indices, in the absence of similar
changes in diastolic measures. Although current guide-
lines would suggest that treatment with anti-hyperten-
sive agents is not indicated in these children, [25] the
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Figure 2 (Top) Relationship between BMI Z-score and Time to
Reperfusion Peak Flow (r = 0.31, p < 0.01) (Middle)
Relationship between Body Fat Percentage and Time to
Reperfusion Peak Flow (r = 0.37, p < 0.01) (Bottom)
Relationship between Serum Triglyceride Concentration and
Time to Reperfusion Peak Flow (r = 0.35, p < 0.01).
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indices and endothelial dysfunction in the context of
obesity would provide further inferences as to the pre-
sence of underlying premature cardiovascular disease in
obese, non-hypertensive, non-apneic, pre-pubertal chil-
dren. It is possible that future studies in such children
may lead to a change in treatment guidelines, which
currently advocate treatment of only those children with
blood pressure exceeding the 95
th percentile, especially
considering the concurrent presence of endothelial
dysfunction.
Of note, while this study did not address the reversi-
bility of endothelial dysfunction in this obese cohort,
several reports have shown that adequate dietary modifi-
cation combined with exercise can return endothelial
function to control levels in obese children, [33,34] and
may therefore suffice.
Conclusions
Cardiovascular morbidity is a well-ascribed complication
of obesity and OSAS in children. In this report, we
show that abnormal endothelial function is significantly
associated with obesity in otherwise healthy, non-hyper-
tensive, pre-pubertal children who do not have any poly-
somnographic evidence of OSAS. Further studies are
warranted to assess the beneficial effect of obesity rever-
sal interventions in this population, and to determine
the potential interactions between OSAS and obesity in
the context of the cardiovascular morbidity associated
with these 2 highly prevalent conditions.
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